Interleukin-6 May Predict Survival in Extracorporeal Membrane Oxygenation Treatment
Extracorporeal membrane oxygenation (ECMO) differs from CPB in duration of days to weeks rather than hours. However, few studies have analyzed the levels of inflammatory mediators during ECMO treatment.
